YouTube Facebook LinkedIn Google+ Twitter Xingrss  

News Blast


April 14, 2006

FLU FIGHTER
Southern Research Institute has been awarded more than $1.4 million by the National Institute of Allergy and Infectious Diseases to develop new high-throughput screening tools to expedite the search for antiviral drugs effective against influenza, including the H5N1 avian flu strain.

STRATEGIC ALLIES
Infinity Pharmaceuticals has entered into a global strategic alliance with Novartis to discover, develop, and commercialize drugs targeting Bcl-2 protein family members for the treatment of a broad range of cancer indications. Members of the Bcl-2 family of proteins are known to facilitate cancer cell survival.

OPEN ACCESS
Northwestern University has joined Open Biosystems’ Open Access RNAi Program. Northwestern’s community of 270 participating research labs gains access to RNAi technology through Open Biosystems’ whole-genome lentiviral shRNAmir libraries.

NSF GRANT
The National Science Foundation has awarded a $500,000 grant to Evolutionary Genomics to continue developing a unique AIDS treatment based on successful adaptations in chimpanzees that keep HIV-type viruses from causing disease.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact  Jay Mulhern, (781) 972-1359, jmulhern@healthtech.com.